Calprotectin in microglia from frontal cortex is up‐regulated in schizophrenia: evidence for an inflammatory process?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Schizophrenia is associated with a number of pathological changes, including alterations in levels of specific proteins. Calprotectin is a novel 36 kDa calcium‐binding protein of the S100 family and appears to be a nonspecific marker of inflammation. Calprotectin has not previously been investigated in brain tissue. Samples of post‐mortem brain tissue from Brodmann area 9 were obtained from prefrontal cortex from subjects with schizophrenia, bipolar affective disorder, major depression, and from controls. Calprotectin levels were determined by ELISA. To determine cellular localization, immunocytochemical and fluorescent double‐labelling analyses were performed. Exogenous calprotectin was added to retinoic acid‐differentiated human SH‐SY5Y neuroblastoma cell cultures in order to investigate mechanisms of action of calprotectin. Calprotectin was detectable in all samples, and mean levels were noted to be highest in schizophrenic brains (P < 0.05) and lowest in controls. Levels were intermediate in bipolar affective disorder and major depression. Exogenous calprotectin appeared to induce dendritic extension in SH‐SY5Y cell culture in a dose‐dependent manner. Calprotectin was found to be localized to microglia. These findings suggest that increased levels of calprotecitn in the brain may reflect inflammatory processes, which play a role in the pathogenesis of major psychiatric disorders. Furthermore, calprotectin may influence dendritic plasticity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634 · cited 2×
“, 2000), diminished neuronal size and glial cell number (Cotter et al., 2002) and aberrant expression of developmental proteins (Beasley et al.”
BackgroundIncreased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Glial cell abnormalities in major psychiatric disorders: the evidence and implications
Cotter, D. R., Pariante, C. M., & Everall, I. P. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00527-5 · Cited by 465
Self-citationCoraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398 · cited 1×
“This receptor, termed the fatty acid translocase (FAT) ⁄ CD36 receptor, is expressed on microglia in Alzheimer’s disease brains (Coraci et al., 2002).”
BackgroundFunctional and clinical aspects of the myelomonocyte protein calprotectin.
Johne, B., Fagerhol, M. K., Lyberg, T., Prydz, H., Brandtzaeg, P., Naess-Andresen, C. F., & Dale, I. (1997) · Molecular Pathology · doi:10.1136/mp.50.3.113 · Cited by 379
Self-citationEvidence for activation of microglia in patients with psychiatric illnesses
Bayer, T. A., Buslei, R., Havas, L., & Falkai, P. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00545-5 · Cited by 323
The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients
Kalus, P., Muller, T. J., Zuschratter, W., & Senitz, D. (2000) · NeuroReport · doi:10.1097/00001756-200011090-00044 · Cited by 146 · cited 3×
“These include reduced synaptic architecture (Kalus et al., 2000), diminished neuronal size and glial cell number (Cotter et al.”
Background
Cited by
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
“Specifically, one postmortem study demonstrated the presence of activated microglia in one of six affective disorder patients [31], and three additional studies reported no differences between depressed patients and controls in microglial density [32–35].”
BackgroundEnache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
“We included 8 studies which investigated microglial markers in post-mortem brains of patients with MDD (Brisch et al., 2017; Busse et al., 2015; Clark et al., 2016; Foster et al., 2006; Steiner et al., 2011, 2008; Torres-Platas et al., 2014; Wesseling et al., 2014)(Table 4).”
BackgroundTranscriptional and Translational Differences of Microglia from Male and Female Brains
Guneykaya, D., Ivanov, A., Hernandez, D. P., Haage, V., Wojtas, B., Meyer, N., Maricos, M., Jordan, P., Buonfiglioli, A., Gielniewski, B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.001 · Cited by 477
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.90 · Cited by 360
Chaudhry, I. B., Hallak, J., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S., Dunn, G., & Deakin, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 279
Metadata
- Authors
- Foster, R., Kandanearatchi, A., Beasley, C., Williams, B., Khan, N., Fagerhol, M. K., & Everall, I. P.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2006-12
- Volume
- 24
- Issue
- 12
- Pages
- 3561-3566
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2089795376
- Cited by
- 63
- References
- 7
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.